Highland Capital Management (Tennessee)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Buy |
10,931
+4,318
| +65% | +$4.41M | 0.6% | 34 |
|
|
2026
Q1 | $6.08M | Sell |
6,613
-4,109
| -38% | -$4.17M | 0.32% | 70 |
|
|
2025
Q4 | $11.5M | Buy |
10,722
+5,966
| +125% | +$5.7M | 0.57% | 36 |
|
|
2025
Q3 | $3.63M | Sell |
4,756
-3,150
| -40% | -$2.34M | 0.18% | 130 |
|
|
2025
Q2 | $6.16M | Sell |
7,906
-1,144
| -13% | -$889K | 0.33% | 72 |
|
|
2025
Q1 | $7.47M | Sell |
9,050
-385
| -4% | -$320K | 0.45% | 50 |
|
|
2024
Q4 | $7.28M | Sell |
9,435
-2,763
| -23% | -$2.29M | 0.42% | 60 |
|
|
2024
Q3 | $10.8M | Sell |
12,198
-300
| -2% | -$270K | 0.62% | 36 |
|
|
2024
Q2 | $11.3M | Sell |
12,498
-881
| -7% | -$705K | 0.67% | 36 |
|
|
2024
Q1 | $10.4M | Buy |
13,379
+29
| +0.2% | +$20.6K | 0.6% | 39 |
|
|
2023
Q4 | $7.78M | Buy |
13,350
+360
| +3% | +$210K | 0.48% | 53 |
|
|
2023
Q3 | $6.98M | Buy |
12,990
+46
| +0.4% | +$23.7K | 0.48% | 47 |
|
|
2023
Q2 | $6.07M | Sell |
12,944
-856
| -6% | -$359K | 0.39% | 64 |
|
|
2023
Q1 | $4.74M | Buy |
13,800
+412
| +3% | +$139K | 0.35% | 90 |
|
|
2022
Q4 | $4.9M | Buy |
13,388
+2,455
| +22% | +$870K | 0.35% | 83 |
|
|
2022
Q3 | $3.54M | Buy |
10,933
+64
| +0.6% | +$20.3K | 0.27% | 111 |
|
|
2022
Q2 | $3.52M | Sell |
10,869
-200
| -2% | -$60K | 0.25% | 126 |
|
|
2022
Q1 | $3.17M | Buy |
11,069
+263
| +2% | +$67.7K | 0.19% | 144 |
|
|
2021
Q4 | $2.98M | Buy |
10,806
+922
| +9% | +$234K | 0.17% | 149 |
|
|
2021
Q3 | $2.28M | Sell |
9,884
-838
| -8% | -$207K | 0.14% | 165 |
|
|
2021
Q2 | $2.46M | Sell |
10,722
-257
| -2% | -$51.6K | 0.15% | 161 |
|
|
2021
Q1 | $2.05M | Sell |
10,979
-858
| -7% | -$168K | 0.13% | 178 |
|
|
2020
Q4 | $2M | Sell |
11,837
-694
| -6% | -$104K | 0.13% | 181 |
|
|
2020
Q3 | $1.85M | Sell |
12,531
-1,920
| -13% | -$297K | 0.13% | 170 |
|
|
2020
Q2 | $2.37M | Sell |
14,451
-315
| -2% | -$48.4K | 0.19% | 131 |
|
|
2020
Q1 | $2.05M | Buy |
14,766
+12,839
| +666% | +$1.76M | 0.19% | 122 |
|
|
2019
Q4 | $253K | Buy |
+1,927
| New | +$223K | 0.02% | 295 |
|
|
2019
Q2 | – | Sell |
-8,499
| Closed | -$1.1M | – | 330 |
|
|
2019
Q1 | $1.1M | Buy |
+8,499
| New | +$1.03M | 0.08% | 220 |
|
|
2018
Q4 | – | Sell |
-13,138
| Closed | -$1.41M | – | 320 |
|
|
2018
Q3 | $1.41M | Buy |
13,138
+186
| +1% | +$18.6K | 0.1% | 190 |
|
|
2018
Q2 | $1.1M | Sell |
12,952
-182
| -1% | -$14.9K | 0.08% | 200 |
|
|
2018
Q1 | $1.02M | Buy |
13,134
+1,801
| +16% | +$145K | 0.08% | 205 |
|
|
2017
Q4 | $957K | Buy |
11,333
+1,273
| +13% | +$108K | 0.07% | 201 |
|
|
2017
Q3 | $861K | Sell |
10,060
-418
| -4% | -$34.3K | 0.07% | 203 |
|
|
2017
Q2 | $862K | Sell |
10,478
-109
| -1% | -$8.89K | 0.07% | 204 |
|
|
2017
Q1 | $891K | Sell |
10,587
-2,552
| -19% | -$204K | 0.07% | 207 |
|
|
2016
Q4 | $966K | Sell |
13,139
-3,964
| -23% | -$295K | 0.08% | 207 |
|
|
2016
Q3 | $1.37M | Buy |
+17,103
| New | +$1.37M | 0.12% | 183 |
|
|
2015
Q4 | – | Sell |
-1,077
| Closed | -$90K | – | 445 |
|
|
2015
Q3 | $90K | Hold |
1,077
| – | – | 0.01% | 333 |
|
|
2015
Q2 | $90K | Buy |
+1,077
| New | +$82.1K | 0.01% | 345 |
|
Other funds holding LLY
Highland Capital Management (Tennessee)'s LLY Position: Q2 2026 in Review
Highland Capital Management (Tennessee) increased its Eli Lilly (LLY) stake by 65% in Q2 2026, buying an estimated $4.41M and bringing the position to 10,931 shares worth $13.1M. The position accounts for 0.6% of the portfolio, ranked #34.
Highland Capital Management (Tennessee) first reported a position in LLY in Q2 2015 and has held it in 39 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Highland Capital Management (Tennessee) held 10,931 shares of Eli Lilly worth $13.1M as of Q2 2026.
- Highland Capital Management (Tennessee) bought 4,318 Eli Lilly shares in Q2 2026, an estimated $4.41M.
- Eli Lilly made up 0.6% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #34 holding.
- Highland Capital Management (Tennessee) first reported a position in Eli Lilly in Q2 2015 and has held it in 39 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.